Article info

Download PDFPDF
Five-Day Intravascular Methotrexate Versus Biweekly Actinomycin-D in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia: A Clinical Randomized Trial

Authors

  1. Address correspondence and reprint requests to Khadijeh Adabi, Moheb Yas Women General Hospital, North Ostad Nejatolahi Avenue, Karim Khan Street, Tehran, Iran, Postcode 1598718311. E-mail: khadabi{at}yahoo.com.

Citation

Yarandi F, Mousavi A, Abbaslu F, et al
Five-Day Intravascular Methotrexate Versus Biweekly Actinomycin-D in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia: A Clinical Randomized Trial

Publication history

  • Received November 2, 2015
  • Accepted January 17, 2016
  • First published June 1, 2016.
Online issue publication 
June 01, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.